v3.25.3
Condensed Balance Sheets - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Current assets    
Cash $ 343,499 $ 953,069
Prepaid expenses 145,417 220,947
Total Current Assets 488,916 1,174,016
Long-term prepaid insurance 8,333
Investments held in Trust Account 71,424,875 69,310,897
TOTAL ASSETS 71,922,124 70,484,913
Current liabilities    
Accrued expenses 97,810 297,787
Accrued offering costs 75,000 75,000
Income tax payable 438,129 61,039
Total Current Liabilities 622,669 445,556
Deferred underwriting fee 2,070,000 2,070,000
TOTAL LIABILITIES 2,692,669 2,515,556
Commitments and Contingencies (Note 6)
Common stock subject to possible redemption, 6,900,000 shares at redemption value of $10.27 and $10.03 per share as of September 30, 2025 and December 31, 2024, respectively 70,891,177 69,233,258
STOCKHOLDERS’ DEFICIT    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding at September 30, 2025 and December 31, 2024
Common stock, $0.0001 par value; 40,000,000 shares authorized; 2,685,750 and 2,685,750 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively (excluding 6,900,000 shares subject to possible redemption) 269 269
Additional paid-in capital
Accumulated deficit (1,661,991) (1,264,170)
Total Stockholders’ Deficit (1,661,722) (1,263,901)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT 71,922,124 70,484,913
Related Party    
Current liabilities    
Promissory note – related party $ 11,730 $ 11,730